Pacesetter's Statement of Support for Cooperative Group Foundation Trials

Cooperative Group trials have long been a cornerstone of progress in cancer treatment, shaping standards of care and offering new hope to patients. As funding uncertainties loom, it is more important than ever to support and advocate for these essential research programs. Pacesetter Clinical Research Group stands committed to ensuring the sustainability and expansion of cooperative group trials, working alongside cooperative group foundation leadership, pharmaceutical, and biotechnology communities to uphold this lifesaving work.

By strengthening trial efficiency, advocating for funding, and demonstrating economic impact, we aim to preserve and enhance the legacy of cooperative group research for future generations. The success of these trials is not just measured in statistics—it is measured in the lives saved, the families given hope, and the communities strengthened by access to groundbreaking treatments.

Our work doesn’t stop at research; it extends to ensuring patients receive the best possible care, reducing treatment side effects, and improving their quality of life. Through innovation and collaboration, we will continue to push boundaries and drive meaningful advancements in oncology. Now more than ever, it is essential to recognize and support cooperative group research as a fundamental pillar of progress in cancer care.